Concentric overcame major technology and regulatory challenges to be first to market in a large, complex device space, treating acute ischemic stroke, which has befuddled big companies and start-ups.
By Stephen Levin
The twin pillars that define the ideal medical device opportunity are a large prospective market and a significant unmet clinical...
Join thousands of industry professionals who rely on In Vivo for daily insights
Already a subscriber?
MedTech Forum 2025 was less MDR-focused than in previous years, as macro issues and exogenous threats were forced further into the center of medtech business thinking.
In a conversation with In Vivo, CEO Jon Congleton discusses Mineralys’s data-rich journey toward an NDA filing, the significance of recent trial wins and how its candidate may offer a dual benefit in blood pressure and renal protection.
Qubit Pharmaceuticals and Sorbonne University launched a quantum AI model that could slash drug synthesis requirements and enable exploration of previously undruggable targets.
